Jubilant Pharmova Limited (NSE:JUBLPHARMA)
India
· Delayed Price · Currency is INR 1,077.00
+9.50 (0.89%)
At close: Dec 5, 2025
Jubilant Pharmova Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 170,498 | 141,360 | 90,432 | 44,418 | 61,740 | 108,375 | Upgrade
|
| Market Cap Growth | -5.97% | 56.32% | 103.60% | -28.06% | -43.03% | 173.43% | Upgrade
|
| Enterprise Value | 192,896 | 161,255 | 117,283 | 70,881 | 82,624 | 136,642 | Upgrade
|
| Last Close Price | 1077.00 | 892.09 | 564.20 | 272.65 | 374.10 | 651.49 | Upgrade
|
| PE Ratio | 35.69 | 16.84 | 117.29 | - | 14.92 | 12.97 | Upgrade
|
| PS Ratio | 2.24 | 1.95 | 1.35 | 0.71 | 1.01 | 1.78 | Upgrade
|
| PB Ratio | 2.59 | 2.27 | 1.67 | 0.82 | 1.16 | 2.29 | Upgrade
|
| P/TBV Ratio | 6.12 | 5.40 | 4.69 | 2.20 | 2.87 | 5.98 | Upgrade
|
| P/FCF Ratio | - | - | 122.87 | - | 25.99 | 8.62 | Upgrade
|
| P/OCF Ratio | 15.31 | 13.19 | 9.31 | 6.72 | 7.37 | 6.07 | Upgrade
|
| EV/Sales Ratio | 2.53 | 2.23 | 1.75 | 1.13 | 1.35 | 2.24 | Upgrade
|
| EV/EBITDA Ratio | 16.08 | 15.39 | 14.78 | 10.97 | 7.75 | 9.31 | Upgrade
|
| EV/EBIT Ratio | 22.12 | 20.07 | 22.42 | 18.91 | 9.84 | 11.94 | Upgrade
|
| EV/FCF Ratio | -193.87 | - | 159.35 | - | 34.78 | 10.87 | Upgrade
|
| Debt / Equity Ratio | 0.44 | 0.44 | 0.68 | 0.68 | 0.60 | 0.60 | Upgrade
|
| Debt / EBITDA Ratio | 2.40 | 2.46 | 4.31 | 5.18 | 2.82 | 1.93 | Upgrade
|
| Debt / FCF Ratio | - | - | 49.78 | - | 13.44 | 2.25 | Upgrade
|
| Asset Turnover | 0.60 | 0.60 | 0.59 | 0.59 | 0.65 | 0.57 | Upgrade
|
| Inventory Turnover | 2.20 | 2.07 | 1.73 | 1.54 | 1.23 | 1.02 | Upgrade
|
| Quick Ratio | 0.81 | 1.03 | 1.18 | 1.26 | 1.34 | 1.64 | Upgrade
|
| Current Ratio | 1.66 | 1.65 | 2.05 | 2.12 | 2.21 | 2.82 | Upgrade
|
| Return on Equity (ROE) | 7.59% | 14.34% | 1.34% | -1.21% | 8.21% | 11.09% | Upgrade
|
| Return on Assets (ROA) | 4.29% | 4.13% | 2.88% | 2.22% | 5.55% | 6.67% | Upgrade
|
| Return on Capital (ROIC) | 5.91% | 5.56% | 3.60% | 2.67% | 6.53% | 7.95% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.60% | 7.60% | 5.40% | 4.00% | 10.00% | 14.50% | Upgrade
|
| Earnings Yield | 2.80% | 5.94% | 0.85% | -1.37% | 6.70% | 7.71% | Upgrade
|
| FCF Yield | -0.58% | -0.31% | 0.81% | -3.46% | 3.85% | 11.60% | Upgrade
|
| Dividend Yield | 0.47% | 0.56% | 0.89% | 1.83% | 1.34% | 0.77% | Upgrade
|
| Payout Ratio | 16.68% | 9.48% | 103.50% | - | 19.34% | 0.18% | Upgrade
|
| Buyback Yield / Dilution | 0.01% | -0.01% | 0.18% | 0.02% | 0.06% | 0.01% | Upgrade
|
| Total Shareholder Return | 0.48% | 0.55% | 1.07% | 1.85% | 1.40% | 0.78% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.